Boston Therapeutics Strengthens its Medical Advisory Board
Boston Therapeutics, Inc. (BTHE-OTCQB), a developer of complex carbohydrate therapeutics to treat diabetes ...
Boston Therapeutics Signs Agreement for Phase III Study of BTI-320
Boston Therapeutics, Inc. (BTHE-OTCQB), a developer of complex carbohydrate therapeutics to treat diabetes, ...
Boston Therapeutics $BTHE Announces Strategic Marketing Agreement for SUGARDOWN®
Boston Therapeutics (BTHE-OTC), a developer of compounds that address blood sugar management and inflammatory ...
Pressure BioSciences, Inc. (PBIO) Reports Fourth Quarter and Fiscal Year 2013 Financial Results
Pressure BioSciences, Inc. (PBIO-OTC), a company that develops, markets, and sells proprietary laboratory ...
ISCO Announces Major Advance in iPS Stem Cell Technology
International Stem Cell Corporation (ISCO:OTCQB), a biotechnology company developing novel stem cell-based ...
ISCO: Third Quarter 2013 Financials and Business Update
International Stem Cell Corp. (ISCO-OTCQB), a biotechnology company developing novel stem cell-based ...
Authentidate Holding Corp. (ADAT) Second Quarter FY 2012 Update
Crystal Research continued its coverage of Authentidate Holding Corp. (ADAT-NASDAQ) with the publication of a ...
Independent Equity Research Report on T3 Motion, Inc. (TTTM)
Crystal Research has initiated coverage on T3 Moton, Inc. (TTTM-NYSE Amex) with the publication of a 56-page ...